Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-22

Clinical Trial Update: Voxelotor CYP and Transporter Cocktail Interaction Study [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 pharmacokinetic interaction study of voxelotor with CYP and transporter substrates; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxbryta (voxelotor)

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-11-22